Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

Inflammatory mechanisms in Alzheimer disease: the role of beta-amyloid/glial interactions

Molecular Psychiatry volume 2, pages 91–95 (1997)Cite this article

Abstract

Recent evidence that insoluble aggregates of beta-amyloid peptide in the brains of Alzheimer patients may elicit neurodestructive immune responses offers the prospect of new therapies to treat this neurodegenerative condition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Connecticut Health Center, 263 Farmington Ave, Farmington, 06030, CT, USA

    J S Pachter

Authors
  1. J S Pachter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pachter, J. Inflammatory mechanisms in Alzheimer disease: the role of beta-amyloid/glial interactions. Mol Psychiatry 2, 91–95 (1997). https://doi.org/10.1038/sj.mp.4000212

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000212

This article is cited by

Search

Advanced search

Quick links